Age
|
Mean ± SD |
0.97 (0.91-1.03, P = 0.313) |
|
tPSA
|
Mean ± SD |
1.00 (1.00-1.00, P = 0.059) |
1.00 (1.00-1.00, P = 0.276) |
PI-RADS score
|
4 |
Reference |
|
|
5 |
1.35 (0.27-6.89, P = 0.714) |
|
ISUP
|
1 |
Reference |
|
|
2 |
0.00 (0.00-Inf, P = 0.991) |
|
|
3 |
0.25 (0.02-2.58, P = 0.244) |
|
|
4 |
0.20 (0.02-2.03, P = 0.174) |
|
|
5 |
0.44 (0.06-3.43, P = 0.434) |
|
Stage
|
TxN0M0 |
Reference |
Reference |
|
TxN1M0 |
0.82 (0.15-4.54, P = 0.822) |
0.79 (0.14-4.36, P = 0.783) |
|
TxNxM1 |
5.14 (1.71-15.46, P = 0.004) |
4.02 (1.25-12.90, P = 0.019) |
Treatment
|
Radiotherapy |
Reference |
|
|
Hormonal therapy |
7.45*10^6 (0.00-Inf, P = 0.991) |
|
|
Comprehensive therapy |
1.11*10^5 (0.00-Inf, P = 0.994) |
|
PCa ADC value
|
Mean ± SD |
1.00 (0.99-1.00, P = 0.437) |
|
PCa volume
|
Mean ± SD |
1.00 (1.00-1.00, P = 0.061) |
|